Back to Journals » Drug Design, Development and Therapy » Volume 9

A fixed-dose combination tablet of gemigliptin and metformin sustained release has comparable pharmacodynamic, pharmacokinetic, and tolerability profiles to separate tablets in healthy subjects

Total article views   HTML views PDF downloads Totals
19,815 Dovepress* 16,363+ 2,079 18,442
PubMed Central* 3,452 829 4,281
Totals 19,815 2,908 22,723
*Since 4 February 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar